Barrieu, M., Chennell, P., Yessaad, M., Bouattour, Y., Wasiak, M., Jouannet, M., . . . Sautou, V. (2022). Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases. Pharmaceutics, 14(1), 118. https://doi.org/10.3390/pharmaceutics14010118
Chicago Style (17th ed.) CitationBarrieu, Marion, Philip Chennell, Mouloud Yessaad, Yassine Bouattour, Mathieu Wasiak, Mireille Jouannet, Yoann Le Basle, and Valérie Sautou. "Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases." Pharmaceutics 14, no. 1 (2022): 118. https://doi.org/10.3390/pharmaceutics14010118.
MLA (9th ed.) CitationBarrieu, Marion, et al. "Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases." Pharmaceutics, vol. 14, no. 1, 2022, p. 118, https://doi.org/10.3390/pharmaceutics14010118.